You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 108812


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 108812

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,261,198 Sep 25, 2038 Genentech Inc XOFLUZA baloxavir marboxil
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape of Argentina Patent AR108812

Last updated: August 3, 2025

Introduction

Patent AR108812, granted in Argentina, pertains to a novel pharmaceutical invention. A comprehensive understanding of its scope, claims, and the broader patent landscape is crucial for stakeholders—pharmaceutical companies, legal practitioners, and investors—aiming to navigate the region’s intellectual property (IP) environment effectively. This analysis dissects each component, examining the patent’s scope, scope-related legal implications, and its position within the evolving patent landscape.

Patent Scope and Claims

Patent Overview

AR108812 was issued by the National Institute of Industrial Property (INPI) of Argentina. The patent primarily focuses on a specific class of pharmaceutical compounds or formulations, possibly related to therapeutic uses, chemical compositions, or manufacturing processes, although the precise details depend on the original patent document. Notably, patents in Argentina follow the civil law tradition, emphasizing clarity and specificity in claims to delineate the invention's scope.

Claim Structure and Classification

The claims of AR108812 define the legal boundary of the patent’s protection. They establish the scope, including:

  • Independent Claims: These encapsulate the core inventive concept. They typically cover the novel compound(s), formulation, or process, expressing broad protection over the primary inventive step.
  • Dependent Claims: These narrow the scope, referencing independent claims and delineating specific embodiments, such as particular chemical variants, dosage forms, or manufacturing parameters.

In general, the scope of the patent hinges on the language, breadth, and number of claims. Broader claims encompass wider inventive territory but are often more vulnerable to validity challenges. Narrow claims, while more defensible, limit the patent's exclusivity.

Claim Analysis

Given the typical structure, we can presuppose AR108812 contains:

  • A claim to a pharmaceutical composition featuring a specific active ingredient or combination,
  • A claim to a method of manufacturing or a method of treatment involving the composition,
  • Possibly, claims to a unique delivery system or dosage regimen.

The key to assessing scope is to evaluate the claim language:

  • Broad claims: Usinggeneric terms like “a pharmaceutical composition comprising compound X,” which could be susceptible to challenges if prior art discloses similar compounds.
  • Narrow claims: Including specific chemical structures, concentrations, or formulation techniques, limiting infringement scope but strengthening novelty.

Legal and Practical Implications

A well-drafted patent claims across the chemical or pharmaceutical spectrum should balance breadth with robustness. Overly broad claims risk invalidity, while overly narrow claims might limit commercial exclusivity.

Patent Landscape of Argentina Concerning AR108812

Existing Patent Environment

Argentina’s pharmaceutical patent landscape is marked by:

  • Incremental innovation focus: Many patents protect manufacturing processes, formulations, and specific compounds rather than broad chemical classes.
  • Patent term policies: The 20-year term from filing, aligned with international standards, with provisions for patent term extensions under specific conditions.

Competitive and Complementary Patents

AR108812 exists within a dynamic environment where:

  • Prior art searches reveal prior disclosures related to similar compounds, formulations, or methods, possibly impacting patent validity.
  • CIP (Certificates of Supplementary Protection) or patent term extensions may be available, enhancing exclusivity.

Comparative Patent Landscape

Globally, similar patents cover chemical entities used for therapeutic purposes, often filed with national agencies like the US Patent and European Patent Office. In Latin America, Argentina often references international patent families, influencing patent scope and strategic positioning.

Key Patent Families and Litigation

While Argentina’s patent enforcement landscape is still developing, the patent ecosystem indicates:

  • A trend towards safeguarding innovative chemical entities and formulations relevant for local manufacturing.
  • Limited litigation history, but increasing patent filings suggest growing strategic importance.

Patent Challenges & Opportunities

The patent landscape presents opportunities for:

  • Partners seeking to enter markets with protected compounds,
  • Generic manufacturers analyzing patent validity, claim scope, and potential license opportunities or non-infringing alternatives.

Legal Status and Patent Lifecycle

Understanding whether AR108812 faces any opposition, has undergone patent term extensions, or been subject to licensing negotiations is pivotal for strategic planning.

Conclusion

AR108812 exemplifies Argentine patenting strategies aimed at protecting specific pharmaceutical innovations. Its scope, defined primarily by the claims’ language, determines market exclusivity and enforceability. The patent landscape in Argentina emphasizes incremental innovation, with a focus on chemical and process patents, making careful claim drafting essential. For companies, recognizing the nuances of this environment enables better management of patent assets, risk mitigation, and opportunity pursuit.

Key Takeaways

  • Precise claim drafting is vital to ensure broad yet defensible patent protection in Argentina’s pharmaceutical landscape.
  • Assess prior art comprehensively to evaluate patent strength and validity, especially for chemical compounds and formulations.
  • Monitor patent family activity for insights into regional and international patent extensions, licensing opportunities, or potential challenges.
  • Be aware of regional patent laws and enforcement efficacy to align patent strategies with local legal realities.
  • Investigation of patent lifecycle status—including possible extensions or litigations—is crucial for long-term strategic planning.

FAQs

  1. What factors influence the scope of a pharmaceutical patent like AR108812 in Argentina?
    The scope is primarily determined by the wording of its claims, including breadth, specificity, and the extent to which it covers chemical compounds, formulations, and methods, balanced with considerations of novelty and inventive step.

  2. How does Argentina’s patent law affect pharmaceutical patent enforcement?
    Argentina adheres to a civil law system emphasizing detailed claim language and procedural rigor. While enforcement mechanisms are evolving, patentees can expect legal recourse through patent infringement actions, though enforcement may vary regionally.

  3. Can similar patents or prior art invalidate AR108812?
    Yes, if prior art demonstrates that the claimed invention is obvious or already disclosed, the patent’s validity could be challenged. Comprehensive patent and prior art searches are essential.

  4. What is the significance of patent claim dependencies in pharmaceutical patents?
    Dependent claims help define specific embodiments of the invention, providing fallback protections and clarifying the scope, which aids in defending validity and enforcing rights.

  5. What strategies should patent holders adopt in Argentina’s patent landscape?
    They should focus on drafting clear, specific claims; monitor patent filings; consider regional patent family strategies; and actively enforce rights against infringements to maximize investment value.


Sources

  1. INPI Argentina Patent Database: Official records and patent documents for AR108812.

  2. Argentine Patent Law (Law No. 24,481): Legal framework governing patents.

  3. WIPO IP Portal: Information on patent landscapes and patent family data.

  4. Global Patent Databases (e.g., Espacenet): For comparative analysis of similar patents.

  5. Legal analyses of Argentine pharmaceutical patent practice: Industry reports and legal reviews for recent case law and enforcement trends.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.